Documenti analoghi

• Comprehensive Assessment of the Transition to Efanesoctocog Alfa Prophylaxis in a Paediatric Haemophilia A Cohort
  di: Rubén Berrueco, et al.
  Pubblicazione: (2026)
• A Psychometric Analysis of the Haemophilia Quality of Life Questionnaire for Adults Physical Health Subscale and Total Scores: Data From the Phase 3 XTEND‐1 Trial in Patients With Severe Haemophilia A
  di: Jérôme Msihid, et al.
  Pubblicazione: (2026)
• Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa
  di: Michael Iarossi, et al.
  Pubblicazione: (2026)
• The First Three Japanese Haemophilia A Patients in Whom Factor VIII Inhibitors Were Observed During Prophylactic Treatment With Efanesoctocog Alfa
  di: Tazuko Tokugawa, et al.
  Pubblicazione: (2025)
• Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND‐1 Study
  di: Angela C. Weyand, et al.
  Pubblicazione: (2025)